Hikma Pharmaceutical | HIK - Capitale Sociale E Riserve

Prezzo Delle Azioni
1,391.00
Cambio Giornaliero
5.00 0.36%
Mensile
10.66%
Annuale
-29.07%
Q2 Previsione
1,361.73




Capitale Sociale E Riserve Cambiamento Data
Almirall EUR 1.49B 24.03M 2025-12
argenx SE USD 6.1B 597.47M 2025-06
AstraZeneca USD 48.67B 2.78B 2025-12
Autolus Therapeutics Ltd USD 178.13M 87.32M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Fresenius EUR 18.62B 320M 2025-09
Galapagos EUR 3.24B 788.91M 2025-12
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
GRIFOLS EUR 5.29B 108.05M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 28.59B 344M 2025-12
Orion EUR 1.12B 162.1M 2026-03
Recordati EUR 1.93B 57.32M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12